Asset-light operations
fully control the high-profit links of the industry chain
HISTORY
-
2008
Sichuan Shangrui Biological medicine Co. LTD was established
-
2009
Shang Ruiyou, Shang Ruixin project research and development
-
2013
Sanrui you obtained the production approval
-
2010
Obtained the first clinical approval for oral variety
-
2014
Shang Ruixin obtained the production approval; Acquired Sichuan Huaao Pharmaceutical Co., LTD
-
2015
Sichuan Ziteng Pharmaceutical Technology Co., LTD was established
-
2016
Ibandronate sodium injection (Shangruiyou) and ketorolac and butriol injection (Shangruixin) were officially sold; Sichuan Shangrui Analysis Co., LTD. (testing center) was established
-
2017
Shang Ruixin and Shang Ruiyou are included in the national medical insurance
-
2019
Shengrui pharmaceutical (production base) established
-
2020
The consistency evalsuation of ibandronate sodium injection (Shenrui) was accepted